NASDAQ:ACRV | Cash Flow Statement | Acrivon Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$17.96M
2026-03-31-$19.04M-$20.54M$14,000.00$13.13M-$33,000.00
2025-12-31-$18.99M-$15.24M$219,000.00$21.52M-$192,000.00
2025-09-30-$18.23M
2025-06-30-$21.01M
2025-03-31-$19.68M-$19.54M$58,000.00$19.21M-$343,000.00
2024-12-31-$22.83M-$17.36M$827,000.00$14.41M-$647,000.00
2024-09-30-$22.44M
2024-06-30-$18.8M
2024-03-31-$16.49M-$17.08M$815,000.00$5.85M-$172,000.00
2023-12-31-$19.25M-$12.37M$1.15M$20.54M-$2.01M
2023-09-30-$14.47M
2023-06-30-$13.91M
2023-03-31-$12.76M-$11.36M$25,000.00$9.33M
2022-12-31-$8.93M-$9.35M$251,000.00-$95.07M$101.86M
2022-09-30-$9.2M
2022-06-30-$5.82M
2022-03-31-$7.22M-$8.42M$415,000.00-$415,000.00
2021-12-31-$4.34M-$3.63M$137,000.00-$137,000.00$99.75M
2021-09-30-$2.44M
2021-06-30-$2.55M
2021-03-31-$6.91M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$77.91M-$63.67M$1.67M$66.1M-$749,000.00
2024-12-31-$80.56M-$65.67M$2.77M-$51.77M$121.03M
2023-12-31-$60.39M-$42.64M$1.29M$50.72M-$1.55M
2022-12-31-$31.17M-$30.12M$2.17M-$141.68M$101.71M
2021-12-31-$16.24M-$13.98M$238,000.00-$238,000.00$112.22M